Logo
x

Search

Subscribe Now

Idiopathic Hypersomnia

Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia

Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia

  • August 13, 2021
Jazz Presents Results of Xywav (Oral Solution) in P-III Withdrawal Study for Adult Patients with Idiopathic Hypersomnia at AAN2021

Jazz Presents Results of Xywav (Oral Solution) in P-III Withdrawal Study for Adult Patients with Idiopathic Hypersomnia at AAN2021

  • April 21, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.